Lonza has plans to expand its drug product development and manufacturing network in Switzerland. The company’s investment also includes the installation of a new aseptic fill and finish line in Stein and the expansion of Drug Product Services in Basel (CH).
Bei einigen der großen internationalen Konzerne der Prozessindustrie gibt es bald neue Führungsköpfe. Neben Dupont, Lyondell Basell und Lonza haben auch Johnson & Johnson, Pfizer und Jubilant Therapeutics Veränderungen in den Chefetagen angekündigt. PROCESS fasst die aktuellen Personalmeldungen für Sie zusammen.
Lonza has expanded its collaboration with Moderna for drug substance manufacturing of the Covid-19 Vaccine Moderna. A new drug substance manufacturing line will also be installed at Lonza’s Geleen site in the Netherlands.
PROCESS Worldwide brings to you the top 5 plant engineering projects of last week from all over the world. Right from the construction of world scale plants to facility expansion projects, find out all the projects making headlines here.
Lonza has plans to make the mega investment in order to build two new mammalian facilities in Visp (CH) and Portsmouth (US). The large-scale facility in Visp (CH) is expected to expand capacity by six 20,000L bioreactors which aims to meet the growing market demand for biologics. The small-scale facility planned in Portsmouth (US) will have a capacity of up to eight 2,000L bioreactors.
Lonza has plans to invest 219 million dollars to construct a new manufacturing complex in Visp, Switzerland. The 2,000 sq m project will comprise a customer dedicated manufacturing line for antibody-drug conjugate payload molecules and will also prove useful for accommodating future small molecule expansions.
Der CDMO-Partner der Biopharma-Industrie, Lonza, hat den Bau eines neuen Produktionskomplexes für kleine Moleküle an seinem Standort in Visp, Schweiz, angekündigt. Insgesamt investiert das Unternehmen rund 180 Millionen Euro in den Neubau.
Swiss company Lonza has announced an expansion to its popular Pyrotec PRO Automated Robotic Solution for endotoxin testing. The new Pyrowave Reader add-on has been designed specifically for use with the sustainable Pyrogene Recombinant Factor C (rFC) Assay.
Lonza has completed the divestment of two of its sites in Ploermel, France and Edinburgh, UK to Next Pharma. With this move, Next Pharma will be adding the two new centers to its existing manufacturing network.